delivering cardiac repair
Solutions for the Heart
Ventrix is a clinical-stage company focused on the development of tissue engineering products for
We are working on novel and innovative biomaterials to harness endogenous repair to improve cardiac function and outcomes for those suffering from Heart Failure.
The VentriGel cardiac repair scaffold is a biomaterial designed specifically for repair of damaged myocardium.
Ventrix has initiated a Phase 1 clinical study for VentriGel, a first-in-class, off-the-shelf, biomaterial scaffold, in heart failure patients with left ventricular dysfunction after a myocardial infarction (heart attack).
Ventrix is available for partnering opportunities.